- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 5/078 - Cells from blood or from the immune system
Patent holdings for IPC class C12N 5/078
Total number of patents in this class: 3131
10-year publication summary
|
149
|
142
|
184
|
225
|
221
|
233
|
208
|
237
|
226
|
212
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Iovance Biotherapeutics, Inc. | 348 |
90 |
| Kyoto University | 2856 |
43 |
| Megakaryon Corporation | 49 |
36 |
| Rubius Therapeutics, Inc. | 65 |
33 |
| Fenwal, Inc. | 680 |
31 |
| FATE Therapeutics, Inc. | 213 |
30 |
| The Regents of the University of California | 20315 |
26 |
| The Board of Trustees of the Leland Stanford Junior University | 6548 |
26 |
| Cellphire, Inc. | 116 |
26 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3020 |
21 |
| Massachusetts Institute of Technology | 10161 |
18 |
| Wisconsin Alumni Research Foundation | 3894 |
17 |
| Children's Medical Center Corporation | 1913 |
17 |
| The Trustees of Columbia University in the City of New York | 3608 |
16 |
| President and Fellows of Harvard College | 6047 |
16 |
| The Trustees of the University of Pennsylvania | 4389 |
16 |
| Cellectis | 404 |
16 |
| The University of Tokyo | 4252 |
16 |
| Board of Regents, The University of Texas System | 5963 |
15 |
| The General Hospital Corporation | 4803 |
15 |
| Other owners | 2607 |